Understanding blockchain – a practical guide for life sciences companies
Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in distributed ledger technology (DLT) on the rise, then it would appear that momentum is building.
Blockchain, through DLT, has the potential to not only improve the way that data is stored, but to open up much easier methods of sharing between companies and stakeholders. The benefits go far beyond this though, and span almost all areas where data touches a life sciences business.
With this in mind, global life sciences software specialist SAP spoke to Michael Townsend, Research Manager at market intelligence firm, IDC Health Insights to look at the current state of play, the challenges and potential rewards of adoption, and the path that life sciences companies can and should take to fully benefit from blockchain.
The result is a report which delivers intelligent insights on the value of blockchain and how our industry can better understand, utilise and reap the best that it has to offer.
Key topics covered include:
- What is the current state of play?
- Where should life sciences companies look to deploy the technology?
- What are the regulatory implications?
- Considerations for internal governance
- What are the benefits of different applications, for example payments, supply chain, clinical trials?
- What do life sciences companies need to do for optimal implementation?
You can read the full report by clicking here or on the button above or below.